A mutation-based gene set predicts survival benefit after immunotherapy across multiple cancers and reveals the immune response landscape

Gợi ý tài liệu liên quan:

• The role of spleen volume change in predicting immunotherapy response in metastatic renal cell carcinoma

  11 trang 37 0 0

• Novel lipometabolism biomarker for chemotherapy and immunotherapy response in breast cancer

  13 trang 27 0 0

• STEAP3 can predict the prognosis and shape the tumor microenvironment of clear cell renal cell carcinoma

  19 trang 26 0 0

• Ebook Cannabis therapy in veterinary medicine: Part 2

  168 trang 24 0 0

• Comprehensive analysis identifies cuproptosis-related gene DLAT as a potential prognostic and immunological biomarker in pancreatic adenocarcinoma

  18 trang 22 0 0

• Deep learning-based tumor microenvironment segmentation is predictive of tumor mutations and patient survival in non-small-cell lung cancer

  18 trang 19 0 0

• Identification and characterization of a FOXA2-regulated transcriptional enhancer at a type 2 diabetes intronic locus that controls GCKR expression in liver cells

  14 trang 17 0 0

• Regulation of HHLA2 expression in kidney cancer and myeloid cells

  14 trang 17 0 0

• Combination of alpha-fetoprotein and neutrophil-to-lymphocyte ratio to predict treatment response and survival outcomes of patients with unresectable hepatocellular carcinoma treated with immune checkpoint

  11 trang 16 0 0

• Artificial intelligence in clinical and genomic diagnostics

  12 trang 15 0 0